Literature DB >> 23932792

Octahydropyrrolo[3,4-c]pyrrole negative allosteric modulators of mGlu1.

Jason T Manka1, Alice L Rodriguez, Ryan D Morrison, Daryl F Venable, Hyekyung P Cho, Anna L Blobaum, J Scott Daniels, Colleen M Niswender, P Jeffrey Conn, Craig W Lindsley, Kyle A Emmitte.   

Abstract

Development of SAR in an octahydropyrrolo[3,4-c]pyrrole series of negative allosteric modulators of mGlu1 using a functional cell-based assay is described in this Letter. The octahydropyrrolo[3,4-c]pyrrole scaffold was chosen as an isosteric replacement for the piperazine ring found in the initial hit compound. Characterization of selected compounds in protein binding assays was used to identify the most promising analogs, which were then profiled in P450 inhibition assays in order to further assess the potential for drug-likeness within this series of compounds.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Allosteric modulator; CNS; GPCR; Glutamate; Octahydropyrrolo[3,4-c]pyrrole; mGlu(1)

Mesh:

Substances:

Year:  2013        PMID: 23932792      PMCID: PMC3901432          DOI: 10.1016/j.bmcl.2013.07.029

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  48 in total

Review 1.  G-protein-coupled receptors: from classical modes of modulation to allosteric mechanisms.

Authors:  Thomas M Bridges; Craig W Lindsley
Journal:  ACS Chem Biol       Date:  2008-07-25       Impact factor: 5.100

2.  In vitro and in vivo SAR of pyrido[3,4-d]pyramid-4-ylamine based mGluR1 antagonists.

Authors:  Simon J Mantell; Karl R Gibson; Simon A Osborne; Graham N Maw; Huw Rees; Peter G Dodd; Ben Greener; Gareth W Harbottle; William A Million; Cedric Poinsard; Steven England; Pauline Carnell; Alison M Betts; Russell Monhemius; Rebecca L Prime
Journal:  Bioorg Med Chem Lett       Date:  2009-03-03       Impact factor: 2.823

Review 3.  Metabotropic glutamate mGlu1 receptor stimulation and blockade: therapeutic opportunities in psychiatric illness.

Authors:  Anne Lesage; Thomas Steckler
Journal:  Eur J Pharmacol       Date:  2010-04-02       Impact factor: 4.432

4.  Discovery and SAR of novel mGluR5 non-competitive antagonists not based on an MPEP chemotype.

Authors:  Alice L Rodriguez; Richard Williams; Ya Zhou; Stacey R Lindsley; Uyen Le; Mark D Grier; C David Weaver; P Jeffrey Conn; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2009-05-03       Impact factor: 2.823

5.  Discovery and biological profile of isoindolinone derivatives as novel metabotropic glutamate receptor 1 antagonists: a potential treatment for psychotic disorders.

Authors:  Satoru Ito; Yukari Hirata; Yasushi Nagatomi; Atsushi Satoh; Gentaroh Suzuki; Toshifumi Kimura; Akio Satow; Shunsuke Maehara; Hirohiko Hikichi; Mikiko Hata; Hisashi Ohta; Hiroshi Kawamoto
Journal:  Bioorg Med Chem Lett       Date:  2009-08-03       Impact factor: 2.823

6.  Effects of mGluR1 antagonism in the dorsal hippocampus on drug context-induced reinstatement of cocaine-seeking behavior in rats.

Authors:  Xiaohu Xie; Donna R Ramirez; Heather C Lasseter; Rita A Fuchs
Journal:  Psychopharmacology (Berl)       Date:  2009-10-22       Impact factor: 4.530

7.  Tricyclic thienopyridine-pyrimidones/thienopyrimidine-pyrimidones as orally efficacious mGluR1 antagonists for neuropathic pain.

Authors:  T K Sasikumar; Li Qiang; Duane A Burnett; William J Greenlee; Cheng Li; Larry Heimark; Birendra Pramanik; Mariagrazia Grilli; Rosalia Bertorelli; Gianluca Lozza; Angelo Reggiani
Journal:  Bioorg Med Chem Lett       Date:  2009-05-03       Impact factor: 2.823

8.  Development of an in vitro drug-drug interaction assay to simultaneously monitor five cytochrome P450 isoforms and performance assessment using drug library compounds.

Authors:  Michael Zientek; Howard Miller; Danielle Smith; Mary Beth Dunklee; Lance Heinle; Archie Thurston; Caroline Lee; Ruth Hyland; Odette Fahmi; Douglas Burdette
Journal:  J Pharmacol Toxicol Methods       Date:  2008-06-25       Impact factor: 1.950

9.  Discovery and in vitro and in vivo profiles of 4-fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methylbenzamide as novel class of an orally active metabotropic glutamate receptor 1 (mGluR1) antagonist.

Authors:  Atsushi Satoh; Yasushi Nagatomi; Yukari Hirata; Satoru Ito; Gentaroh Suzuki; Toshifumi Kimura; Shunsuke Maehara; Hirohiko Hikichi; Akio Satow; Mikiko Hata; Hisashi Ohta; Hiroshi Kawamoto
Journal:  Bioorg Med Chem Lett       Date:  2009-07-23       Impact factor: 2.823

Review 10.  Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.

Authors:  P Jeffrey Conn; Arthur Christopoulos; Craig W Lindsley
Journal:  Nat Rev Drug Discov       Date:  2009-01       Impact factor: 84.694

View more
  3 in total

1.  A novel class of succinimide-derived negative allosteric modulators of metabotropic glutamate receptor subtype 1 provides insight into a disconnect in activity between the rat and human receptors.

Authors:  Hyekyung P Cho; Darren W Engers; Daryl F Venable; Colleen M Niswender; Craig W Lindsley; P Jeffrey Conn; Kyle A Emmitte; Alice L Rodriguez
Journal:  ACS Chem Neurosci       Date:  2014-05-15       Impact factor: 4.418

2.  Further evaluation of novel structural modifications to scaffolds that engender PLD isoform selective inhibition.

Authors:  Matthew C O'Reilly; Sarah A Scott; H Alex Brown; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2014-11-15       Impact factor: 2.823

3.  Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: development of a [3.3.0]-based series and other piperidine bioisosteres.

Authors:  Douglas J Sheffler; Michael T Nedelcovych; Richard Williams; Stephen C Turner; Brittany B Duerk; Megan R Robbins; Sataya B Jadhav; Colleen M Niswender; Carrie K Jones; P Jeffrey Conn; R Nathan Daniels; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2014-01-13       Impact factor: 2.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.